Literature DB >> 36117797

Evaluation of a nitinol stone retrieval basket as an alternative to biopsy forceps for biopsy of suspected upper tract genitourinary malignancies.

Daniel J McClelland1, Raven D Spencer2, Ian W McArdle2, Adam M Luchey1, John T Barnard1, Ali J Hajiran1, Chad B Crigger1, Gautum Agarwal3, Chad E Morley1.   

Abstract

Background: The anatomical nature of the ureteroscopic approach for biopsy of upper urothelial tract tumors requires the utilization of small instruments, often limiting biopsy specimen quality. This leads to lower-than-desired tumor grading accuracy and malignancy detection capabilities on the initial evaluation of upper tract tumor specimens. This is problematic because optimal treatment of upper tract urothelial carcinoma (UTUC) depends on early disease detection and subsequent accurate diagnosis. Objective: The objective of our study was to compare the biopsy capabilities of two ureteroscopic biopsy instruments - biopsy forceps and the nitinol stone retrieval basket.
Methods: We performed a retrospective analysis of ten patients who underwent biopsy of an upper tract mass with either instrument. Average specimen size, muscularis propria presence, and malignancy detection sensitivity were the variables of interest.
Results: The nitinol stone retrieval basket obtained larger biopsy samples than the biopsy forceps, with average biopsy volumes being 0.0674 cm3 and 0.0075 cm3, respectively (P = 0.00017); this was the only statistically significant result of our study. Muscularis propria was present in 31% (4/13) of the biopsies with the nitinol stone retrieval basket, whereas 0% (0/5) of the biopsy forceps biopsies contained muscularis propria (P = 0.2778). Regarding malignancy detection sensitivity, the nitinol stone retrieval basket biopsies identified malignancy in 100% of the specimens that had confirmed malignancy; the biopsy forceps only detected malignancy 40% of the time (P = 0.4134).
Conclusion: These findings suggest that the nitinol stone retrieval basket is a useful diagnostic tool for UTUC, although further investigation is warranted to determine its superiority compared to biopsy forceps. Copyright:
© 2022 Urology Annals.

Entities:  

Keywords:  Neoadjuvant chemotherapy; Piranha biopsy forceps; nephroureterectomy; nitinol stone retrieval basket; transitional cell carcinoma; upper tract urothelial carcinoma; upper urinary tract biopsy; ureteroscopy with biopsy; urinary tract cancer

Year:  2022        PMID: 36117797      PMCID: PMC9472316          DOI: 10.4103/ua.ua_89_21

Source DB:  PubMed          Journal:  Urol Ann        ISSN: 0974-7796


INTRODUCTION

Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of all urothelial cancer cases in the United States, and the frequency of UTUC is increasing.[12] The diagnosis and treatment of these carcinomas often depend on the pathology results associated with respective biopsies; ureteroscopy with biopsy remains the current standard for obtaining tissue biopsies for UTUC diagnosis. The anatomical nature of this approach requires the utilization of small instruments which limits biopsy specimen size – the most important factor with regards to overall biopsy quality.[3] In addition to specimen size, another important biopsy quality consideration is muscularis propria presence within the specimen, which is also limited by instrument size.[4] Since the determination of tumor grade and stage greatly depends on these two biopsy characteristics, UTUC diagnosis is difficult and often inaccurate.[5] UTUC has a high mortality risk if not managed effectively early in the disease course.[6] Therefore, obtaining an adequate initial biopsy is critical for early disease detection, accurate pathologic diagnosis, and subsequent determination of optimal treatment. Patients with high-grade disease and/or parenchymal invasion are eligible for neoadjuvant chemotherapy in addition to nephroureterectomy.[78] However, patients with low-grade tumors and/or many comorbidities are managed less aggressively with nephron-sparing treatments, such as endoscopic resection or segmental ureterectomy.[7] This further emphasizes the importance of accurate initial UTUC diagnosis with correct tumor grading and staging, since under-staging tumors may result in patient ineligibility for adjuvant chemotherapy after nephroureterectomy due to kidney loss and decreased glomerular filtration rate.[9] Numerous biopsy instruments exist, including but not limited to: Graspers, snares, brushes, aspiration catheters, biopsy forceps, and nitinol stone retrieval baskets.[1011] For all the reasons mentioned previously, determining the most reliable instrument (s) and technique (s) for consistently procuring high-quality upper tract biopsies would be beneficial for the accurate diagnosis and management of UTUC in the future practice. The purpose of this study was to compare biopsy adequacy of two commonly used instruments – biopsy forceps and nitinol stone retrieval basket – when obtaining upper tract biopsies in patients with UTUC.

MATERIALS AND METHODS

In a study approved by the Institutional Review Board (Protocol # 1810295735), we performed a retrospective review of ten total patients who underwent ureteroscopy with biopsy, nine of which who also underwent nephroureterectomy, for upper tract tumors between the years of 2016 and 2019 by four board-certified attending surgeons at our tertiary care institution (Ruby Memorial Hospital at West Virginia Medicine in Morgantown, WV). Informed consent from participants was not required, as this was a retrospective study. Data extracted from the electronic medical record were patient demographics and general characteristics, number of biopsy specimens and specimen size, presence of muscularis propria within biopsy specimens, and final pathology results of tumors after subsequent nephroureterectomy [Tables 1–3]. Ureteroscopy was performed with a flexible ureteroscope, and biopsies were taken with either the Piranha biopsy forceps [©2021 Boston Scientific Corporation, 300 Boston Scientific Way, Marlborough, MA 01752-1234; Figure 1] or the Cook Medical nitinol stone retrieval basket [© 2022 Cook Medical LLC, P. O. Box 4195, Bloomington, IN 47402-4195; Figure 2] depending on surgeon preference. Ureteral access sheaths were not utilized, as their insertion could have potentially sheered ureteral masses not visualized on computed tomography urography and result in not identifying ureteral masses during ureteroscopy. After tissue specimens were collected successfully, the ureteroscope and biopsy device were removed as a single unit. This was done to avoid specimen loss in the narrow working channel of the ureteroscope. Repeat biopsies were taken until we had obtained a grossly visible specimen in the biopsy device. Specimens were labeled based on their respective biopsy device. The decision to place a ureteral stent was based on surgeon preference.
Table 1

General patient characteristics

MaleFemaleTotal
Number of patients (%)5 (50)5 (50)10
Age68.0±13.4972.4±16.3270.2±14.30
BMI29.29±4.2626.11±9.2527.70±6.99
ASA number*3.0±03.2±0.453.1±0.32
Number of smokers (%)4/5 (80)5/5 (100)9/10 (90)
Pack years28.0±19.2453.4±33.2040.70±28.87
Ureteral stent placed intraoperatively (%)2/5 (40)4/5 (80)6/10 (60)
Nephrostomy tube placed intraoperatively (%)**1/10 (10)1/10 (10)2/10 (20)

*Recorded 1 month prior to biopsy, **Due to tumor obstruction. BMI: Body mass index, ASA: American Standards Association

Table 3

Biopsy specimen pathology results of each instrument compared to final pathology results status-postnephroureterectomy

Piranha biopsy forcepsNitinol stone retrieval basketFinal pathology results
Minute fragments of crushed urothelial tissueLow-grade UCHigh-grade UC
No malignancy identifiedLow-grade UCLow-grade UC
Low-grade UCLow-grade UCLow-grade UC
Low-grade UCLow-grade UCHigh-grade UC
Crushed urothelial tissueLow-grade UCLow-grade UC
Low-grade UCNo malignancy identified*
Low-grade UCLow-grade UC
Low-grade UCLow-grade UC
Low-grade UCHigh-grade UC
High-grade UCN/A**

*Likely due to low tumor burden resolution with biopsy and holmium laser prior to nephroureterectomy, **Patient deceased prior to nephroureterectomy. UC: Urothelial carcinoma, N/A: Not available

Figure 1

Piranha biopsy forceps

Figure 2

Cook medical nitinol stone retrieval basket

General patient characteristics *Recorded 1 month prior to biopsy, **Due to tumor obstruction. BMI: Body mass index, ASA: American Standards Association Comparison of biopsy quality parameters between the piranha biopsy forceps and cook medical nitinol stone retrieval basket *P values determined by a two-tailed t-test for biopsy size comparison and Fisher’s exact tests for both muscularis propria presence and sensitivity value comparisons; cut-off P value for statistical significance was 0.05, **Units are cm3, ***Sensitivity values calculated using biopsy specimen pathology results and final pathology results after nephroureterectomy, ****One of the patients passed away prior to nephroureterectomy, so no subsequent pathological evaluation to confirm malignancy was performed. N/A: Not available Biopsy specimen pathology results of each instrument compared to final pathology results status-postnephroureterectomy *Likely due to low tumor burden resolution with biopsy and holmium laser prior to nephroureterectomy, **Patient deceased prior to nephroureterectomy. UC: Urothelial carcinoma, N/A: Not available Piranha biopsy forceps Cook medical nitinol stone retrieval basket Biopsy sizes were determined by the measurements provided in their respective pathology reports. Pathology reports from each biopsy were used to determine muscularis propria presence, as well as the tumor grade. An instrument’s sensitivity of malignancy detection value was determined by comparing the initial biopsy tumor grades of each biopsy to the final pathology results after respective nephroureterectomy. Average biopsy sizes from the two biopsy devices were compared using a two-tailed t-test; a Fisher exact test was performed to compare the instruments’ biopsy specimen muscularis propria presence as well as the sensitivity of malignancy detection. The cutoff P value to determine statistical significance was set at 0.05.

RESULTS

Of the ten total patients, five patients underwent biopsies with both the nitinol stone retrieval basket and the biopsy forceps, and five patients underwent biopsies with the nitinol stone retrieval basket only. There were five and 13 total biopsy specimens obtained by the biopsy forceps and nitinol stone retrieval basket, respectively. Some biopsies contained multiple pieces of tissue, so there were nine total pieces of tissue obtained with the biopsy forceps and 32 with the nitinol stone retrieval basket. Of the ten patients, six had a ureteral stent placed after their procedure, two patients were admitted overnight for nephrostomy tube placement, and two patients were left without a stent or nephrostomy tube. In the two cases in which a nephrostomy tube was placed, guidewire placement was prevented due to tumor obstruction [Table 2].
Table 2

Comparison of biopsy quality parameters between the piranha biopsy forceps and cook medical nitinol stone retrieval basket

Piranha biopsy forcepsNitinol stone retrieval basketTotalP*
Specimens biopsied51318N/A
Total tissue pieces obtained93241N/A
Specimen size**0.00756±0.0110.0674±0.0670.0375±0.0640.0001631
Muscularis propria presence within specimen (%)0/5 (0)4/13 (30.7)4/18 (22.2)0.2778
Malignancy detection sensitivity (%)***2/5 (40%)12/12 (100)****15/18 (83.3)0.4134

*P values determined by a two-tailed t-test for biopsy size comparison and Fisher’s exact tests for both muscularis propria presence and sensitivity value comparisons; cut-off P value for statistical significance was 0.05, **Units are cm3, ***Sensitivity values calculated using biopsy specimen pathology results and final pathology results after nephroureterectomy, ****One of the patients passed away prior to nephroureterectomy, so no subsequent pathological evaluation to confirm malignancy was performed. N/A: Not available

The biopsies obtained by the nitinol stone retrieval basket were approximately nine times larger than those of the biopsy forceps, with average sizes being 0.0075 cm3 with the biopsy forceps and 0.0674 cm3 with the Nitinol stone retrieval basket [Figure 3]. This was the only statistically significant result in our study (P = 0.00017). None (0/5) of the specimens obtained with the biopsy forceps contained muscularis propria, whereas 31% (4/13) specimens obtained with the nitinol stone retrieval basket contained muscle tissue (P = 0.2778). Two patients reported hematuria, and one patient reported flank pain at their postoperative clinic visits. There were no other reported complications.
Figure 3

Example of biopsy specimen size comparison between the biopsy forceps and nitinol stone retrieval basket

Example of biopsy specimen size comparison between the biopsy forceps and nitinol stone retrieval basket Nine out of the ten patients in this study ultimately underwent nephroureterectomy to determine final pathology; one patient passed away before nephroureterectomy [Table 3]. Of the nine patients who underwent nephroureterectomy, three were found to have high-grade UC on final pathology, five had low-grade UC, and one patient had no identifiable malignancy. In the three cases in which high-grade disease was found after nephroureterectomy, all of the biopsy specimens demonstrated low-grade disease, regardless of the instrument used. In the patient who did not undergo nephroureterectomy, the biopsy with the Nitinol stone retrieval basket revealed the high-grade disease. In the eight patients found to have UC on final pathologic diagnosis, malignancy was identified in all biopsies taken with the nitinol stone retrieval basket (100% sensitivity), whereas only two of the five biopsies taken with the biopsy forceps revealed malignancy (40% sensitivity) (P = 0.4134). In the three patients whose biopsies either demonstrated no malignancy or crushed urothelial tissue with the biopsy forceps, the nitinol stone retrieval basket demonstrated UC. In the single patient who had no identifiable malignancy after nephroureterectomy, the nitinol stone retrieval basket biopsy revealed low-grade disease; the base of the mass was fulgurated with holmium laser after this biopsy was performed.

DISCUSSION

The management of UTUC has evolved over the years, with neoadjuvant chemotherapy becoming increasingly important. Previously, radical nephroureterectomy was the standard treatment for all cases of UTUC. Although this method is effective in achieving oncologic control, renal function deterioration and morbidity from the operation itself are important considerations. Nephron-sparing therapies such as endoscopic resection or segmental ureterectomy are now considered viable treatment options in certain patient populations (i.e., low-grade tumors, many co-morbidities).[78] Since multiple potential treatments exist, early detection and accurate diagnosis of UTUC is crucial for optimal management. Ureteroscopy with biopsy remains the standard for grading and staging UTUC; however, obtaining adequate biopsies is often challenging due to the small instrument size.[34] We attempted to address this issue by comparing multiple biopsy quality parameters of two instruments commonly used for upper tract mass biopsy. First, it is important to note that our study was limited by a sample size of ten total patients. This small sample size was likely the primary reason for the lack of statistical significance in some of our results. Another consideration is that one of the ten patients passed away before nephroureterectomy and final pathologic diagnosis; this particular patient had high-grade disease based on nitinol stone basket biopsy pathology. In the patient with no detectable malignancy on final pathology, the nitinol stone basket biopsy revealed low-grade UC. This patient had a 0.5 cm mass visualized during ureteroscopy in the renal pelvis, which was fulgurated at the base with the holmium laser after the biopsy was performed. In this case, it is likely that the combination of biopsy and subsequent laser fulguration of the base led to the successful removal of the patient’s entire tumor burden before nephroureterectomy. Despite these considerations, we were still able to achieve notable findings within our study. Difference in biopsy tissue size held statistical significance in favor of the nitinol stone retrieval basket, which yielded an average biopsy size nearly nine times larger than the biopsy forceps (P = 0.00017). This result is especially meaningful since the gross size of tissue material obtained via biopsy is likely the most important factor with regards to malignancy detection and accurate tumor grading in UTUC.[48] Results for our other variables– muscularis propria presence within biopsy samples and sensitivity of malignancy detection– also favored the nitinol stone retrieval basket over biopsy forceps, although these were not statistically significant. With regard to malignancy detection, the nitinol stone basket produced an impressive sensitivity value of 100% compared to 40% demonstrated by the biopsy forceps. We consider this result to be noteworthy since diagnostic modalities with higher sensitivities are particularly useful in the detection of detrimental diseases, like UTUC, in which prompt treatment has a more favorable prognosis. The combination of the nitinol stone basket’s ability to obtain larger biopsy samples and muscularis propria presence within specimens likely contributed to its higher sensitivity value when compared to biopsy forceps. All in all, our findings support the notion that biopsies obtained by the nitinol stone retrieval basket are useful in the diagnostic evaluation of upper urogenital tract tumors. However, due to our small sample size and lack of statistical significance in multiple parameters, specific instrument superiority (or lack thereof) is yet to be established. Further studies to determine this are warranted since early disease detection and diagnostic accuracy of UTUC are crucial for optimal patient care.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.

Authors:  Matthew G Kaag; Rebecca L O'Malley; Padraic O'Malley; Guilherme Godoy; Mang Chen; Marc C Smaldone; Ronald L Hrebinko; Jay D Raman; Bernard Bochner; Guido Dalbagni; Michael D Stifelman; Samir S Taneja; William C Huang
Journal:  Eur Urol       Date:  2010-06-25       Impact factor: 20.096

2.  European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.

Authors:  Morgan Rouprêt; Richard Zigeuner; Juan Palou; Andreas Boehle; Eero Kaasinen; Richard Sylvester; Marko Babjuk; Willem Oosterlinck
Journal:  Eur Urol       Date:  2011-01-14       Impact factor: 20.096

3.  Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps.

Authors:  Nir Kleinmann; Kelly A Healy; Scott G Hubosky; David Margel; Marluce Bibbo; Demetrius H Bagley
Journal:  J Endourol       Date:  2013-11-19       Impact factor: 2.942

4.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

5.  Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach.

Authors:  E Guarnizo; C P Pavlovich; M Seiba; D L Carlson; E D Vaughan; R E Sosa
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma.

Authors:  Vishal Vashistha; Ahmad Shabsigh; Debra L Zynger
Journal:  Arch Pathol Lab Med       Date:  2013-03       Impact factor: 5.534

7.  National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.

Authors:  Sumanta Kumar Pal; Neeraj Agarwal; Stephen Anthony Boorjian; Noah M Hahn; Arlene O Siefker-Radtke; Peter E Clark; Elizabeth R Plimack
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

8.  Systematic mapping of nephroureterectomy specimens removed for urothelial cancer: pathological findings and clinical correlations.

Authors:  J P McCarron; S B Chasko; G F Gray
Journal:  J Urol       Date:  1982-08       Impact factor: 7.450

9.  Ureteroscopic biopsy in the upper urinary tract.

Authors:  O M Abdel-Razzak; H Ehya; A Cubler-Goodman; D H Bagley
Journal:  Urology       Date:  1994-09       Impact factor: 2.649

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.